Seqalis Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$791K
Seqalis General Information
Description
Provider of laboratory testing, scientific advisory and research and development services. The company offers immuno-oncology, cytogenomics, histopathology, DNA and RNA sequencing, digital PCR, paternity testing and biobanking for anatomical pathology, cytogenetics and molecular biology fields.
Contact Information
Website
www.seqalis.com
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Primary Office
- 25 avenue Georges Lemaitre
- 6041 Gosselies
- Belgium
+32 071 00 00 00
Seqalis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Debt - General | 01-Jan-2007 | $791K | 00000 | Completed | Generating Revenue |
Seqalis Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jean-Luc Henrioul | Chief Operating Officer | ||
| Jean-Francois Ghidetti | Executive Director |
Seqalis Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Seqalis Investments (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BloomX | 02-Feb-2023 | 0000 00000 | 000 | Machinery (B2B) | |
| OncoDNA | 09-Aug-2021 | 00000 0000 | 0000 | Biotechnology | |
| OncoDNA | 01-Sep-2016 | 00000 0000 | 00.000 | Biotechnology | |
| OncoDNA | 01-Dec-2012 | 00000 0000 | 00.000 | Biotechnology | |
| DNAVision | 29-Apr-2006 | Early Stage VC | 000 | Other Healthcare Services |